ADVIL ALLERGY SINUS Drug Patent Profile
✉ Email this page to a colleague
When do Advil Allergy Sinus patents expire, and what generic alternatives are available?
Advil Allergy Sinus is a drug marketed by Glaxosmithkline and is included in one NDA. There is one patent protecting this drug.
This drug has thirty-four patent family members in eighteen countries.
The generic ingredient in ADVIL ALLERGY SINUS is chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Generic Entry Outlook for Advil Allergy Sinus
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be February 28, 2027. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
Summary for ADVIL ALLERGY SINUS
International Patents: | 34 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in ADVIL ALLERGY SINUS? | ADVIL ALLERGY SINUS excipients list |
DailyMed Link: | ADVIL ALLERGY SINUS at DailyMed |

DrugPatentWatch® Estimated Generic Entry Opportunity Date for ADVIL ALLERGY SINUS
Generic Entry Date for ADVIL ALLERGY SINUS*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Anatomical Therapeutic Chemical (ATC) Classes for ADVIL ALLERGY SINUS
US Patents and Regulatory Information for ADVIL ALLERGY SINUS
ADVIL ALLERGY SINUS is protected by one US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of ADVIL ALLERGY SINUS is See Plans and Pricing.
This potential generic entry date is based on patent See Plans and Pricing.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting ADVIL ALLERGY SINUS
Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | ADVIL ALLERGY SINUS | chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride | TABLET;ORAL | 021441-001 | Dec 19, 2002 | OTC | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ADVIL ALLERGY SINUS
When does loss-of-exclusivity occur for ADVIL ALLERGY SINUS?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Argentina
Patent: 2543
Estimated Expiration: See Plans and Pricing
Australia
Patent: 03301188
Estimated Expiration: See Plans and Pricing
Patent: 05251733
Estimated Expiration: See Plans and Pricing
Patent: 11200912
Estimated Expiration: See Plans and Pricing
Canada
Patent: 08611
Estimated Expiration: See Plans and Pricing
Patent: 68443
Estimated Expiration: See Plans and Pricing
Chile
Patent: 03002653
Estimated Expiration: See Plans and Pricing
China
Patent: 26035
Estimated Expiration: See Plans and Pricing
Patent: 1065112
Estimated Expiration: See Plans and Pricing
Patent: 2406642
Estimated Expiration: See Plans and Pricing
Colombia
Patent: 40087
Estimated Expiration: See Plans and Pricing
European Patent Office
Patent: 72206
Estimated Expiration: See Plans and Pricing
Patent: 55561
Estimated Expiration: See Plans and Pricing
Hong Kong
Patent: 78494
Estimated Expiration: See Plans and Pricing
Patent: 66602
Estimated Expiration: See Plans and Pricing
Japan
Patent: 41228
Estimated Expiration: See Plans and Pricing
Patent: 06515299
Estimated Expiration: See Plans and Pricing
Patent: 08501692
Estimated Expiration: See Plans and Pricing
Mexico
Patent: 05006331
Estimated Expiration: See Plans and Pricing
Patent: 06013919
Estimated Expiration: See Plans and Pricing
New Zealand
Patent: 0289
Estimated Expiration: See Plans and Pricing
Patent: 2030
Estimated Expiration: See Plans and Pricing
Peru
Patent: 040973
Estimated Expiration: See Plans and Pricing
Patent: 081072
Estimated Expiration: See Plans and Pricing
Portugal
Patent: 72206
Estimated Expiration: See Plans and Pricing
Russian Federation
Patent: 22262
Estimated Expiration: See Plans and Pricing
Patent: 05122403
Estimated Expiration: See Plans and Pricing
South Africa
Patent: 0504908
Estimated Expiration: See Plans and Pricing
Spain
Patent: 68217
Estimated Expiration: See Plans and Pricing
Taiwan
Patent: 13598
Estimated Expiration: See Plans and Pricing
Patent: 0413004
Estimated Expiration: See Plans and Pricing
Patent: 0609004
Estimated Expiration: See Plans and Pricing
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering ADVIL ALLERGY SINUS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hong Kong | 1078494 | 非甾體抗炎藥、解充血藥和抗組胺藥的組合物 (COMPOSITIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS DECONGESTANTS AND ANTI-HISTAMINES) | See Plans and Pricing |
Peru | 20081072 | COMPOSICIONES DE ANTI-HISTAMINICOS, DESCONGESTIVOS, ANTITUSIVOS Y DROGAS ANTI-INFLAMATORIOS NO ESTEROIDALES | See Plans and Pricing |
Hong Kong | 1166602 | COMPOSITIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS DECONGESTANTS AND ANTI-HISTAMINES | See Plans and Pricing |
New Zealand | 540289 | Pharmaceutical compositions of non-steroidal anti-inflammatory drugs (NSAID), decongestants and anti-histamines | See Plans and Pricing |
European Patent Office | 1572206 | COMPOSITIONS DE MEDICAMENTS ANTI-INFLAMMATOIRES NON-STEROIDAUX, DECONGESTIONNANTS ET ANTIHISTAMINIQUES (COMPOSITIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS DECONGESTANTS AND ANTI-HISTAMINES) | See Plans and Pricing |
Canada | 2568443 | COMPRIME MULTICOUCHE COMPRENANT DES MEDICAMENTS ANTI-INFLAMMATOIRES NON STEROIDIENS, DES DECONGESTIONNANTS ET DES ANTIHISTAMINIQUES NON SEDATIFS (MULTI-LAYER TABLET COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, DECONGESTANTS AND NON-SEDATING ANTIHISTAMINES) | See Plans and Pricing |
European Patent Office | 1755561 | COMPRIME MULTICOUCHE COMPRENANT DES MEDICAMENTS ANTI-INFLAMMATOIRES NON STEROIDIENS, DES DECONGESTIONNANTS ET DES ANTIHISTAMINIQUES NON SEDATIFS (MULTI-LAYER TABLET COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS DECONGESTANTS AND NON-SEDATING ANTIHISTAMINES) | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |